Story perspectives

Sanctions Cripple Iran’s Medicine Imports, Nearly 800 Drugs Missing

By Drooid · Sep 21, 2026, 2:39 PM UTC · How we work

Left

Sanctions Trigger Drug Shortages

The United States announced tighter sanctions on Iran’s import of medicines and pharmaceutical inputs in September 2026.
These sanctions, together with Israel’s late-March strike on a pharmaceutical factory, have deepened shortages of nearly 800 medicines, leaving patients without essential treatments.
Banks and suppliers have over-complied, avoiding any transactions that could involve Iranian pharmaceutical imports.
Iranian pharmacies report insurance companies owe almost 800 trillion rials, preventing purchase of imported specialty drugs.

Right

Detainment Demonstrates Resolve

The United States announced tighter sanctions on Iran’s ability to import medicines and related pharmaceutical inputs in September 2026.
U.S. officials confined the Iranian UN delegation to their hotel and UN, barring visits to Costco, Sam’s Club and Walmart, adviser Theo Wold said demonstrates resolve.
President Donald Trump is set to speak at the United Nations General Assembly on Tuesday, September 20, 2026.
Iranian President Masoud Pezeshkian will address the Assembly on September 21, 2026.

Blindspot

Iranian pharmacies report that sanctions have created shortages of nearly 800 medicines, leaving patients unable to obtain essential treatments, according to pharmacy officials.
Within this story's sources, this angle appears mainly in Left-leaning coverage and receives less attention in Right-leaning coverage.

History

Historical Context

The 1979 Iranian Revolution triggered U.S. sanctions that year, severely restricting Iran’s import of medical supplies and pharmaceuticals for decades across multiple sectors. The U.S. Treasury’s Office of Foreign Assets Control listed over 1,200 Iranian entities in 1995, freezing $2.5 billion in assets linked to medical trade. Today, the September 2026 U.S. sanctions echo legacy, with officials like Theo Wold and President Donald Trump imposing medicine bans as Iran’s UN delegation remains confined. The renewed pressure threatens Iran’s ability to treat 800 patients, prompting humanitarian NGOs and the World Health Organization to demand exemption clauses in sanctions frameworks.

1 of 4

Sanctions Trigger Drug Shortages

The United States announced tighter sanctions on Iran’s import of medicines and pharmaceutical inputs in September 2026.
These sanctions, together with Israel’s late-March strike on a pharmaceutical factory, have deepened shortages of nearly 800 medicines, leaving patients without essential treatments.
Banks and suppliers have over-complied, avoiding any transactions that could involve Iranian pharmaceutical imports.
Iranian pharmacies report insurance companies owe almost 800 trillion rials, preventing purchase of imported specialty drugs.

1 / 4